Structure-activity relationships for a series of compounds that inhibit aggregation of the Alzheimer's peptide, Aβ42.
Structure-activity relationships for a series of compounds that inhibit aggregation of the Alzheimer's peptide, Aβ42.
复制标题
DOI:
10.1111/cbdd.12341
复制
发表时间:
2014-11
影响因子:
3
通讯作者:
Hecht MH
中科院分区:
文献类型:
--
作者:
McKoy AF;Chen J;Schupbach T;Hecht MH
Inhibiting aggregation of the amyloid‐beta (Aβ) peptide may be an effective strategy for combating Alzheimer's disease. As the high‐resolution structure of the toxic Aβaggregate is unknown, rational design of small molecule inhibitors is not possible, and inhibitors are best isolated by high‐throughput screening. We applied high‐throughput screening to a collection of 65 000 compounds to identify compoundD737as an inhibitor of Aβaggregation.D737diminished the formation of oligomers and fibrils, and reduced Aβ42‐induced cytotoxicity. Most importantly,D737increased the life span and locomotive ability of transgenic flies in a Drosophila melanogaster model of Alzheimer's disease (J Biol Chem, 287, 2012, 38992). To explore the chemical features that makeD737an effective inhibitor of Aβ42 aggregation and toxicity, we tested a small collection of eleven analogues ofD737. Overall, the ability of a compound to inhibit Aβaggregation was a good predictor of its efficacy in prolonging the life span and locomotive ability of transgenic flies expressing human Aβ42 in the central nervous system. Two compounds (D744andD830) with fluorine substitutions on an aromatic ring were effective inhibitors of Aβ42 aggregation and increased the longevity of transgenic flies beyond that observed for the parent compound,D737.
登录
查看更多内容
影响因子:
21.8
作者:
通讯作者:
--
影响因子:
15
作者:
Chen J;Armstrong AH;Koehler AN;Hecht MH
通讯作者:
Hecht MH
影响因子:
2.9
作者:
Petkova, AT;Yau, WM;Tycko, R
通讯作者:
Tycko, R
DOI:
10.1073/pnas.262663499
发表时间:
2002-12-24
影响因子:
11.1
作者:
Petkova, AT;Ishii, Y;Tycko, R
通讯作者:
Tycko, R
影响因子:
2.9
作者:
Necula, Mihaela;Breydo, Leonid;Glabe, Charles G.
通讯作者:
Glabe, Charles G.